Avoro Capital Advisors LLC Diversified Active

Location: NEW YORK, NY

CIK: 0001633313 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 14, 2015

Total Value ($000): $363,116 (100.0% shares, 0.0% debt)

Holdings (31)

FOLD AMICUS THERAPEUTICS INC 17.9%

Value ($000) $64,951 Shares 4,590,199 Est. Cost $7.88 Unrealized +52.6%

SRNE SORRENTO THERAPEUTICS INC 10.6%

Value ($000) $38,526 Shares 2,186,520 Est. Cost $8.90 Unrealized +44.4%

— MIRATI THERAPEUTICS INC. 8.7%

Value ($000) $31,470 Shares 1,000,000 Est. Cost $30.78 Unrealized —

— LION BIOTECHNOLOGIES INC 7.4%

Value ($000) $26,805 Shares 2,923,065 Est. Cost $11.33 Unrealized —

— ONCOTHYREON INC 5.8%

Value ($000) $21,008 Shares 5,617,003 Est. Cost $2.20 Unrealized —

ACAD ACADIA PHARMACEUTICALS INC 5.7%

Value ($000) $20,731 Shares 495,000 Est. Cost $38.70 Unrealized 0.0%

— AGENUS - INC 5.2%

Value ($000) $18,979 Shares 2,199,137 Est. Cost $4.29 Unrealized —

VNDA VANDA PHARMACEUTICALS INC 5.0%

Value ($000) $18,257 Shares 1,438,693 Est. Cost $10.78 Unrealized 0.0%

— LA JOLLA PHARMACEUTICAL CO. 4.1%

Value ($000) $15,000 Shares 611,999 Est. Cost $19.89 Unrealized —

— IGI LABORATORIES INC 3.0%

Value ($000) $11,048 Shares 1,753,682 Est. Cost $7.23 Unrealized —

— CELLDEX THERAPEUTICS INC 2.4%

Value ($000) $8,886 Shares 352,350 Est. Cost $25.22 Unrealized —

VCYT VERACYTE INC 2.3%

Value ($000) $8,450 Shares 758,497 Est. Cost $9.84 Unrealized 0.0%

— PERNIX THERAPEUTICS HOLDINGS 2.0%

Value ($000) $7,401 Shares 1,250,167 Est. Cost $9.63 Unrealized —

— INNOCOLL AG 2.0%

Value ($000) $7,277 Shares 497,422 Est. Cost $10.70 Unrealized —

— AXOVANT SCIENCES LTD. 1.9%

Value ($000) $6,929 Shares 340,000 Est. Cost $20.38 Unrealized —

— TONIX PHARMACEUTICALS HLDG 1.9%

Value ($000) $6,775 Shares 755,300 Est. Cost $6.32 Unrealized —

— NEURODERM LTD. 1.6%

Value ($000) $5,697 Shares 371,111 Est. Cost $15.35 Unrealized —

— FLAMEL TECHNOLOGIES 1.6%

Value ($000) $5,674 Shares 267,747 Est. Cost $17.92 Unrealized —

— BELLICUM PHARMACEUTICALS INC 1.5%

Value ($000) $5,584 Shares 262,515 Est. Cost $23.11 Unrealized —

— RECEPTOS INC 1.4%

Value ($000) $5,036 Shares 26,500 Est. Cost $122.51 Unrealized —

HRTX HERON THERAPEUTICS INC 1.3%

Value ($000) $4,674 Shares 150,000 Est. Cost $18.81 Unrealized 0.0%

— ALLIQUA BIOMEDICAL INC 1.2%

Value ($000) $4,216 Shares 800,000 Est. Cost $5.27 Unrealized —

VCEL VERICEL CORP. 1.1%

Value ($000) $3,868 Shares 1,083,486 Est. Cost $2.86 Unrealized +19.8%

ADAPY ADAPTIMMUNE THERAPEUTICS-ADR 0.9%

Value ($000) $3,371 Shares 183,900 Est. Cost $18.33 Unrealized —

— FORTRESS BIOTECH INC. 0.9%

Value ($000) $3,123 Shares 929,531 Est. Cost $3.36 Unrealized —

— TRILLIUM THERAPEUTICS INC 0.6%

Value ($000) $2,060 Shares 94,400 Est. Cost $20.12 Unrealized —

— HEAT BIOLOGICS INC 0.6%

Value ($000) $2,011 Shares 335,102 Est. Cost $6.28 Unrealized —

BIIB BIOGEN INC 0.5%

Value ($000) $1,818 Shares 4,500 Est. Cost $401.33 Unrealized 0.0%

— TARGACEPT INC 0.5%

Value ($000) $1,639 Shares 587,315 Est. Cost $2.93 Unrealized —

CLLS CELLECTIS - ADR 0.3%

Value ($000) $1,082 Shares 30,000 Est. Cost $34.57 Unrealized —

— SPDR SERIES TRUST - S&P BIOTECH 0.2%

Value ($000) $770 Shares 350,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
FOLD	AMICUS THERAPEUTICS INC	4,590,199	$64,951	17.9%	$7.88	+52.6%	Common	03152W109
SRNE	SORRENTO THERAPEUTICS INC	2,186,520	$38,526	10.6%	$8.90	+44.4%	Common	83587F202
—	MIRATI THERAPEUTICS INC.	1,000,000	$31,470	8.7%	$30.78	—	Common	60468T105
—	LION BIOTECHNOLOGIES INC	2,923,065	$26,805	7.4%	$11.33	—	Common	53619R102
—	ONCOTHYREON INC	5,617,003	$21,008	5.8%	$2.20	—	Common	682324108
ACAD	ACADIA PHARMACEUTICALS INC	495,000	$20,731	5.7%	$38.70	0.0%	Common	004225108
—	AGENUS - INC	2,199,137	$18,979	5.2%	$4.29	—	Common	00847G705
VNDA	VANDA PHARMACEUTICALS INC	1,438,693	$18,257	5.0%	$10.78	0.0%	Common	921659108
—	LA JOLLA PHARMACEUTICAL CO.	611,999	$15,000	4.1%	$19.89	—	Common	503459604
—	IGI LABORATORIES INC	1,753,682	$11,048	3.0%	$7.23	—	Common	449575109
—	CELLDEX THERAPEUTICS INC	352,350	$8,886	2.4%	$25.22	—	Common	15117B103
VCYT	VERACYTE INC	758,497	$8,450	2.3%	$9.84	0.0%	Common	92337F107
—	PERNIX THERAPEUTICS HOLDINGS	1,250,167	$7,401	2.0%	$9.63	—	Common	71426V108
—	INNOCOLL AG	497,422	$7,277	2.0%	$10.70	—	Sponsored ADR	45780Q103
—	AXOVANT SCIENCES LTD.	340,000	$6,929	1.9%	$20.38	—	Common	G0750W104
—	TONIX PHARMACEUTICALS HLDG	755,300	$6,775	1.9%	$6.32	—	Common	890260201
—	NEURODERM LTD.	371,111	$5,697	1.6%	$15.35	—	Common	M74231107
—	FLAMEL TECHNOLOGIES	267,747	$5,674	1.6%	$17.92	—	Sponsored ADR	338488109
—	BELLICUM PHARMACEUTICALS INC	262,515	$5,584	1.5%	$23.11	—	Common	079481107
—	RECEPTOS INC	26,500	$5,036	1.4%	$122.51	—	Common	756207106
HRTX	HERON THERAPEUTICS INC	150,000	$4,674	1.3%	$18.81	0.0%	Common	427746102
—	ALLIQUA BIOMEDICAL INC	800,000	$4,216	1.2%	$5.27	—	Common	019621200
VCEL	VERICEL CORP.	1,083,486	$3,868	1.1%	$2.86	+19.8%	Common	92346J108
ADAPY	ADAPTIMMUNE THERAPEUTICS-ADR	183,900	$3,371	0.9%	$18.33	—	Sponsored ADR	00653A107
—	FORTRESS BIOTECH INC.	929,531	$3,123	0.9%	$3.36	—	Common	34960Q109
—	TRILLIUM THERAPEUTICS INC	94,400	$2,060	0.6%	$20.12	—	Common	89620X506
—	HEAT BIOLOGICS INC	335,102	$2,011	0.6%	$6.28	—	Common	42237K102
BIIB	BIOGEN INC	4,500	$1,818	0.5%	$401.33	0.0%	Common	09062X103
—	TARGACEPT INC	587,315	$1,639	0.5%	$2.93	—	Common	87611R306
CLLS	CELLECTIS - ADR	30,000	$1,082	0.3%	$34.57	—	Sponsored ADS	15117K103
—	SPDR SERIES TRUST - S&P BIOTECH	350,000	$770	0.2%	—	—	Put	78464A950